Home  /  Resource Library  /  Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Real world study on CAR-T Brexucabtagene autoleucel for treatment of relapsed mantle cell lymphoma.